These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2132 related items for PubMed ID: 7600567

  • 1. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.
    Mujoo K, Cheung L, Murray JL, Rosenblum MG.
    Cancer Immunol Immunother; 1995 May; 40(5):339-45. PubMed ID: 7600567
    [Abstract] [Full Text] [Related]

  • 2. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG, Marks JW, Cheung LH.
    Cancer Chemother Pharmacol; 1999 May; 44(4):343-8. PubMed ID: 10447583
    [Abstract] [Full Text] [Related]

  • 3. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cells.
    Rosenblum MG, Cheung L, Kim SK, Mujoo K, Donato NJ, Murray JL.
    Cancer Immunol Immunother; 1996 Feb; 42(2):115-21. PubMed ID: 8620520
    [Abstract] [Full Text] [Related]

  • 4. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.
    Rosenblum MG, Cheung L, Mujoo K, Murray JL.
    Cancer Immunol Immunother; 1995 May; 40(5):322-8. PubMed ID: 7600565
    [Abstract] [Full Text] [Related]

  • 5. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
    Rosenblum MG, Murray JL, Cheung L, Rifkin R, Salmon S, Bartholomew R.
    Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
    [Abstract] [Full Text] [Related]

  • 6. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of cellular trafficking and cytotoxicity of 9.2.27-gelonin immunotoxins targeted against the high-molecular-weight melanoma-associated antigen.
    Chan MC, Murphy RM.
    Cancer Immunol Immunother; 1999 Feb; 47(6):321-9. PubMed ID: 10203062
    [Abstract] [Full Text] [Related]

  • 8. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
    Rosenblum MG, Cheung LH, Liu Y, Marks JW.
    Cancer Res; 2003 Jul 15; 63(14):3995-4002. PubMed ID: 12873997
    [Abstract] [Full Text] [Related]

  • 9. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG, Zuckerman JE, Marks JW, Rotbein J, Allen WR.
    Mol Biother; 1992 Sep 15; 4(3):122-9. PubMed ID: 1445665
    [Abstract] [Full Text] [Related]

  • 10. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
    Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG.
    Cancer Immunol Immunother; 1991 Sep 15; 34(3):198-204. PubMed ID: 1756537
    [Abstract] [Full Text] [Related]

  • 11. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
    Sivam G, Pearson JW, Bohn W, Oldham RK, Sadoff JC, Morgan AC.
    Cancer Res; 1987 Jun 15; 47(12):3169-73. PubMed ID: 3495329
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ, Cumber AJ, Henry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA.
    Cancer Res; 1990 Dec 01; 50(23):7519-26. PubMed ID: 2253201
    [Abstract] [Full Text] [Related]

  • 13. Antileukemic activity of recombinant humanized M195-gelonin immunotoxin in nude mice.
    Xu Y, Xu Q, Rosenblum MG, Scheinberg DA.
    Leukemia; 1996 Feb 01; 10(2):321-6. PubMed ID: 8637241
    [Abstract] [Full Text] [Related]

  • 14. Recombinant immunotoxins directed against the c-erb-2/HER2/neu oncogene product: in vitro cytotoxicity, pharmacokinetics, and in vivo efficacy studies in xenograft models.
    Rosenblum MG, Shawver LK, Marks JW, Brink J, Cheung L, Langton-Webster B.
    Clin Cancer Res; 1999 Apr 01; 5(4):865-74. PubMed ID: 10213223
    [Abstract] [Full Text] [Related]

  • 15. The antileukemic efficacy of an immunotoxin composed of a monoclonal anti-Thy-1 antibody disulfide linked to the ribosome-inactivating protein gelonin.
    Scott CF, Goldmacher VS, Lambert JM, Chari RV, Bolender S, Gauthier MN, Blättler WA.
    Cancer Immunol Immunother; 1987 Apr 01; 25(1):31-40. PubMed ID: 3496157
    [Abstract] [Full Text] [Related]

  • 16. Selective antitumor effect of thioether-linked immunotoxins composed of gelonin and monoclonal antibody to alpha-fetoprotein or its F(ab')2 fragment.
    Masuda K, Takahashi K, Hirano K, Takagishi Y.
    Tumour Biol; 1994 Apr 01; 15(3):175-83. PubMed ID: 7521059
    [Abstract] [Full Text] [Related]

  • 17. Effects of monoclonal antibody, recombinant interferon-gamma, and tumor necrosis factor-alpha in the treatment of human melanoma xenografts.
    Gridley DS, Slater JM, Stickney DR.
    J Biol Response Mod; 1989 Dec 01; 8(6):593-602. PubMed ID: 2513378
    [Abstract] [Full Text] [Related]

  • 18. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [Abstract] [Full Text] [Related]

  • 19. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies.
    French RR, Penney CA, Browning AC, Stirpe F, George AJ, Glennie MJ.
    Br J Cancer; 1995 May 15; 71(5):986-94. PubMed ID: 7734325
    [Abstract] [Full Text] [Related]

  • 20. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
    Wenning LA, Murphy RM.
    Biotechnol Bioeng; 1999 Mar 05; 62(5):562-75. PubMed ID: 10099565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 107.